IntelliAM aiming for significant growth with £5 million Aquis IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTate & Lyle Regulatory News (TATE)

Share Price Information for Tate & Lyle (TATE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 604.50
Bid: 606.00
Ask: 606.50
Change: 2.50 (0.42%)
Spread: 0.50 (0.083%)
Open: 604.00
High: 608.00
Low: 600.00
Prev. Close: 602.00
TATE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Tate & Lyle Completes Re-Alignment of Eaststarch Joint Venture

2 Nov 2015 13:22

2 November 2015 – Tate & Lyle PLC

Tate & Lyle completes re-alignment of Eaststarch joint venture

Tate & Lyle PLC (Tate & Lyle) announces that it has completed the transaction to re-align the Eaststarch corn wet milling joint venture in Europe with Archer Daniels Midland Company (ADM). The signing of the agreement to re-align Eaststarch was announced on 21 April 2015.

Following completion, Tate & Lyle has acquired full ownership of the more speciality-focused plant in Slovakia and exited the predominantly Bulk Ingredients plants in Bulgaria, Turkey and Hungary. Tate & Lyle has also received the cash consideration of €240 million. Customary working capital adjustments will be made in due course.

END

For more information contact Tate & Lyle PLC:

Christopher Marsh, VP, Investor and Media Relations

Tel: +44 (0) 20 7257 2110 or Mobile: +44 (0) 7796 192 688

Andrew Lorenz (FTI Consulting), Media Relations

Tel: +44 (0) 203 727 1323 or Mobile: +44 (0) 7775 641 807

About Tate & Lyle:

Tate & Lyle is a global provider of ingredients and solutions to the food, beverage and other industries, with operations in over 30 locations worldwide.

Tate & Lyle operates through two global divisions, Speciality Food Ingredients and Bulk Ingredients, supported by our Innovation and Commercial Development and Global Operations groups. The Group's strategy is to become a leading global provider of Speciality Food Ingredients through a disciplined focus on growth, and by driving Bulk Ingredients for sustained cash generation to fuel this growth.

Speciality Food Ingredients consists of three platforms: Texturants, which includes speciality starches and stabilisers; Sweeteners, which comprises nutritive sweeteners and our range of no-calorie sweeteners including SPLENDA® Sucralose; and our Health and Wellness portfolio which includes speciality fibres and our salt-reduction offering. Additionally, our Food Systems business provides a wide variety of blended ingredient solutions.

Tate & Lyle Bulk Ingredients includes bulk sweeteners, industrial starches and fermentation products (primarily acidulants). Corn co-products from both divisions are primarily sold as animal feed.

Tate & Lyle is listed on the London Stock Exchange under the symbol TATE.L. American Depositary Receipts trade under TATYY. In the year to 31 March 2015, Tate & Lyle sales totalled £2.7 billion. For more information, please visit http://www.tateandlyle.com. SPLENDA® is a trademark of Heartland Consumer Products LLC.

View source version on businesswire.com: http://www.businesswire.com/news/home/20151102005931/en/

Copyright Business Wire 2015

Date   Source Headline
1st Apr 20222:15 pmRNSDisposal completion
1st Apr 20222:00 pmRNSTotal Voting Rights
31st Mar 20227:00 amRNSAcquisition
24th Mar 20222:00 pmRNSHolding(s) in Company
24th Mar 202211:00 amRNSDirectorate Change
21st Mar 20222:00 pmRNSHolding(s) in Company
18th Mar 20223:30 pmRNSHolding(s) in Company
10th Mar 20222:00 pmRNSHolding(s) in Company
9th Mar 20222:00 pmRNSHolding(s) in Company
1st Mar 20229:22 amRNSTotal Voting Rights
18th Feb 20222:00 pmRNSHolding(s) in Company
17th Feb 20222:00 pmRNSHolding(s) in Company
14th Feb 20222:00 pmRNSHolding(s) in Company
11th Feb 20227:00 amRNSTrading Statement
10th Feb 20222:00 pmRNSHolding(s) in Company
9th Feb 20227:00 amRNSDirectorate Change
3rd Feb 20224:00 pmRNSHolding(s) in Company
1st Feb 20223:30 pmRNSHolding(s) in Company
21st Jan 20222:00 pmRNSHolding(s) in Company
17th Jan 20222:00 pmRNSHolding(s) in Company
12th Jan 20224:00 pmRNSHolding(s) in Company
10th Jan 20223:45 pmRNSChange of Registered Office
10th Jan 20223:40 pmRNSDirector/PDMR Shareholding
4th Jan 20224:00 pmRNSBlock listing Interim Review
10th Dec 20212:09 pmRNSHolding(s) in Company
9th Dec 20213:10 pmRNSDirector/PDMR Shareholding
1st Dec 20219:58 amRNSTotal Voting Rights
18th Nov 20214:15 pmRNSHolding(s) in Company
5th Nov 202111:45 amRNSDirector/PDMR Shareholding
4th Nov 20217:00 amRNSHalf-year Report
3rd Nov 20216:01 pmRNSDirectorate Change
29th Oct 202111:15 amRNSHolding(s) in Company
21st Oct 20214:45 pmRNSRestatement re Primary Products Disposal
18th Oct 20212:30 pmRNSHolding(s) in Company
13th Oct 202112:30 pmRNSHolding(s) in Company
6th Oct 20213:30 pmRNSHolding(s) in Company
6th Oct 202111:15 amRNSDirector/PDMR Shareholding
4th Oct 20212:30 pmRNSDirector/PDMR Shareholding
4th Oct 20217:00 amRNSTotal Voting Rights
30th Sep 202112:00 pmRNSResult of General Meeting
13th Sep 20214:30 pmRNSCircular re. KPS Partnership
1st Sep 20219:58 amRNSTotal Voting Rights
18th Aug 202110:10 amRNSDirector/PDMR Shareholding
11th Aug 20214:00 pmRNSDirector/PDMR Shareholding
2nd Aug 20213:15 pmRNSTotal Voting Rights
29th Jul 202112:45 pmRNSResult of AGM
23rd Jul 20215:00 pmRNSHolding(s) in Company
22nd Jul 20213:15 pmRNSDirector/PDMR Shareholding
16th Jul 20213:30 pmRNSHolding(s) in Company
12th Jul 20214:00 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.